---
category: news
title: "AI therapeutics announces start of Phase II Trial of LAM-002A (apilimod dimesylate) for treatment of COVID-19 patients"
excerpt: "AI Therapeutics announced the start of Phase II clinical trial for the treatment of newly diagnosed COVID-19 patients in collaboration with Yale University."
publishedDateTime: 2020-07-27T13:21:00Z
webUrl: "https://www.eurekalert.org/pub_releases/2020-07/cl-sh072420.php"
type: article
quality: 13
heat: 13
published: false

provider:
  name: EurekAlert!
  domain: eurekalert.org

topics:
  - AI

images:
  - url: "https://www.eurekalert.org/socialshare/EurekAlert-bluebg_Twitter_1200x675.jpg"
    width: 1200
    height: 675
    isCached: true

secured: "l4fLl3NimcFOJV7HdaAVCNbKX20BRviyi9swQWuFRuzT3ZRh/HjewHd0QlEXZg4mIrYcSWW3yfbaQfyIFgeFJ3N0wwTGCfSMnhEVM42Judez+mBkOtUZ6ROT/HEGwCPDQX0KwIt/2bf+IHpZgbUX23WUzOldP6cSWSq2mT1Hkn6s7QCwoNpcJyvWLMNbJR/CH73TNU7Phq/jooefT3sWN+V6+gU+htfGHDWyFfC2F8mGkICM6lDqBfVttYnnv/yqiI2MzMECeN9zC05f1+vlXeXtMYTPPT3esdFW59jnT5WPfGp4+khhobnyF0RGlKRY8Qj/YMUxFj89vxAJ/AucLg==;MOuIxw050pKoPpr+NzffVg=="
---

